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Clinics and pathology 
Disease 
Chronic myelogenous leukemia (CML) in accelerated 
phase (AP-CML). 
Epidemiology 
Only one case to date, a female patient, aged a 40 at the 
time of the AP-CML. 
Prognosis 
Chronic phase of CML lasted 2 years before 
progression into an accelerated phase accompanied 
with the appearance of the t(7;17); 2 months later, a 
blast crisis occurred, and the patient died 9 months after 
the AP-CML, 33 months after initial diagnosis of CML. 
Cytogenetics 
Cytogenetics morphological 
A t(9;22)(q34;q11) was, indeed, present. 
Cytogenetics molecular 
Cryptic translocation; recognized by multicolor FISH 
plus locus-specific FISH. 
Genes involved and Proteins 
Note: The gene involved on chromosome 7 is 
undefined, due to a lack of material for further analysis, 
but it seems to be a gene of the plexin family, with, 
perhaps, a sema domain, a plexin repeat, and an 





DNA / RNA 
At least 15 exons; various splicing. 
Protein 
Possesses 2 RNA recognition motifs; likely to be a 
RNA binding protein; may play a role in RNA 
metabolism in the cytoplasm; the mouse homolog is 
ubiquitous, and particularly active in the brain 
development. 
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